In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species

Shu Hua Xiao, Jennifer Keiser, Jacques Chollet, Jürg Utzinger, Yuxiang Dong, Yvette Endriss, Jonathan L Vennerstrom, Marcel Tanner

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

Schistosomiasis is a parasitic disease that remains of considerable public health significance in tropical and subtropical environments. Since the mainstay of schistosomiasis control is chemotherapy with a single drug, praziquantel, drug resistance is a concern. Here, we present new data on the antischistosomal properties of representative synthetic 1,2,4-trioxolanes (OZs). Exposure of adult Schistosoma mansoni for 24 h to a medium containing 20 μg/ml OZ209 reduced worm motor activity, induced tegumental alterations, and killed worms within 72 h. While exposure of S. mansoni to OZ78S had no apparent effect, addition of hemin reduced worm motor activity and caused tegumental damage. Administration of single 200-mg/kg of body weight oral doses of OZ78, OZ209, and OZ288 to mice harboring a juvenile S. mansoni infection resulted in worm burden reductions of 82.0 to 95.4%. In the adult infection model in mice, single 400-mg/kg doses of these compounds resulted in a maximum total worm burden reduction of 52.2%. High worm burden reductions (71.7 to 86.5%) were observed after administration of single 200-mg/kg doses of OZ78 and OZ288 to hamsters infected with either juvenile or adult S. mansoni. A single 200-mg/kg dose of OZ78 to hamsters infected with adult Schistosoma japonicum resulted in total and female worm burden reductions of 94.2 to 100%. Our results, along with the low toxicity, metabolic stability, and good pharmacokinetic properties of the OZs, indicate the potential for the development of novel broad-spectrum antischistosomal OZ drug candidates.

Original languageEnglish (US)
Pages (from-to)1440-1445
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume51
Issue number4
DOIs
StatePublished - Apr 1 2007

Fingerprint

Schistosoma mansoni
Schistosomiasis
Cricetinae
Motor Activity
Schistosoma japonicum
Praziquantel
Schistosomiasis mansoni
Hemin
Parasitic Diseases
Drug Resistance
Pharmaceutical Preparations
Pharmacokinetics
Public Health
Body Weight
Drug Therapy
Infection
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. / Xiao, Shu Hua; Keiser, Jennifer; Chollet, Jacques; Utzinger, Jürg; Dong, Yuxiang; Endriss, Yvette; Vennerstrom, Jonathan L; Tanner, Marcel.

In: Antimicrobial Agents and Chemotherapy, Vol. 51, No. 4, 01.04.2007, p. 1440-1445.

Research output: Contribution to journalArticle

Xiao, Shu Hua ; Keiser, Jennifer ; Chollet, Jacques ; Utzinger, Jürg ; Dong, Yuxiang ; Endriss, Yvette ; Vennerstrom, Jonathan L ; Tanner, Marcel. / In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species. In: Antimicrobial Agents and Chemotherapy. 2007 ; Vol. 51, No. 4. pp. 1440-1445.
@article{c80d3f18acc24b2a823a71edbb5258bb,
title = "In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species",
abstract = "Schistosomiasis is a parasitic disease that remains of considerable public health significance in tropical and subtropical environments. Since the mainstay of schistosomiasis control is chemotherapy with a single drug, praziquantel, drug resistance is a concern. Here, we present new data on the antischistosomal properties of representative synthetic 1,2,4-trioxolanes (OZs). Exposure of adult Schistosoma mansoni for 24 h to a medium containing 20 μg/ml OZ209 reduced worm motor activity, induced tegumental alterations, and killed worms within 72 h. While exposure of S. mansoni to OZ78S had no apparent effect, addition of hemin reduced worm motor activity and caused tegumental damage. Administration of single 200-mg/kg of body weight oral doses of OZ78, OZ209, and OZ288 to mice harboring a juvenile S. mansoni infection resulted in worm burden reductions of 82.0 to 95.4{\%}. In the adult infection model in mice, single 400-mg/kg doses of these compounds resulted in a maximum total worm burden reduction of 52.2{\%}. High worm burden reductions (71.7 to 86.5{\%}) were observed after administration of single 200-mg/kg doses of OZ78 and OZ288 to hamsters infected with either juvenile or adult S. mansoni. A single 200-mg/kg dose of OZ78 to hamsters infected with adult Schistosoma japonicum resulted in total and female worm burden reductions of 94.2 to 100{\%}. Our results, along with the low toxicity, metabolic stability, and good pharmacokinetic properties of the OZs, indicate the potential for the development of novel broad-spectrum antischistosomal OZ drug candidates.",
author = "Xiao, {Shu Hua} and Jennifer Keiser and Jacques Chollet and J{\"u}rg Utzinger and Yuxiang Dong and Yvette Endriss and Vennerstrom, {Jonathan L} and Marcel Tanner",
year = "2007",
month = "4",
day = "1",
doi = "10.1128/AAC.01537-06",
language = "English (US)",
volume = "51",
pages = "1440--1445",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species

AU - Xiao, Shu Hua

AU - Keiser, Jennifer

AU - Chollet, Jacques

AU - Utzinger, Jürg

AU - Dong, Yuxiang

AU - Endriss, Yvette

AU - Vennerstrom, Jonathan L

AU - Tanner, Marcel

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Schistosomiasis is a parasitic disease that remains of considerable public health significance in tropical and subtropical environments. Since the mainstay of schistosomiasis control is chemotherapy with a single drug, praziquantel, drug resistance is a concern. Here, we present new data on the antischistosomal properties of representative synthetic 1,2,4-trioxolanes (OZs). Exposure of adult Schistosoma mansoni for 24 h to a medium containing 20 μg/ml OZ209 reduced worm motor activity, induced tegumental alterations, and killed worms within 72 h. While exposure of S. mansoni to OZ78S had no apparent effect, addition of hemin reduced worm motor activity and caused tegumental damage. Administration of single 200-mg/kg of body weight oral doses of OZ78, OZ209, and OZ288 to mice harboring a juvenile S. mansoni infection resulted in worm burden reductions of 82.0 to 95.4%. In the adult infection model in mice, single 400-mg/kg doses of these compounds resulted in a maximum total worm burden reduction of 52.2%. High worm burden reductions (71.7 to 86.5%) were observed after administration of single 200-mg/kg doses of OZ78 and OZ288 to hamsters infected with either juvenile or adult S. mansoni. A single 200-mg/kg dose of OZ78 to hamsters infected with adult Schistosoma japonicum resulted in total and female worm burden reductions of 94.2 to 100%. Our results, along with the low toxicity, metabolic stability, and good pharmacokinetic properties of the OZs, indicate the potential for the development of novel broad-spectrum antischistosomal OZ drug candidates.

AB - Schistosomiasis is a parasitic disease that remains of considerable public health significance in tropical and subtropical environments. Since the mainstay of schistosomiasis control is chemotherapy with a single drug, praziquantel, drug resistance is a concern. Here, we present new data on the antischistosomal properties of representative synthetic 1,2,4-trioxolanes (OZs). Exposure of adult Schistosoma mansoni for 24 h to a medium containing 20 μg/ml OZ209 reduced worm motor activity, induced tegumental alterations, and killed worms within 72 h. While exposure of S. mansoni to OZ78S had no apparent effect, addition of hemin reduced worm motor activity and caused tegumental damage. Administration of single 200-mg/kg of body weight oral doses of OZ78, OZ209, and OZ288 to mice harboring a juvenile S. mansoni infection resulted in worm burden reductions of 82.0 to 95.4%. In the adult infection model in mice, single 400-mg/kg doses of these compounds resulted in a maximum total worm burden reduction of 52.2%. High worm burden reductions (71.7 to 86.5%) were observed after administration of single 200-mg/kg doses of OZ78 and OZ288 to hamsters infected with either juvenile or adult S. mansoni. A single 200-mg/kg dose of OZ78 to hamsters infected with adult Schistosoma japonicum resulted in total and female worm burden reductions of 94.2 to 100%. Our results, along with the low toxicity, metabolic stability, and good pharmacokinetic properties of the OZs, indicate the potential for the development of novel broad-spectrum antischistosomal OZ drug candidates.

UR - http://www.scopus.com/inward/record.url?scp=34247102609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247102609&partnerID=8YFLogxK

U2 - 10.1128/AAC.01537-06

DO - 10.1128/AAC.01537-06

M3 - Article

VL - 51

SP - 1440

EP - 1445

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -